1Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with Lanthanide chelates in normal brain:contrast due to magnetic susceptibility effects[J]. Magn Resort Med, 1988,6(2) : 164-174.
2Petrella JR, Provenzale JM. MR perfusion imaging of the brian : tech-niques and applications[J]. A JR, 175(1) : 207-219.
3Sugahara T, fgorogi y, Kochi M ,et al.Perfusion-sensitive MR imagingof gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques [J]. ANJR Am J Neuroradiol, 2001,22 (7) :1306-1315.
4Sorenen AG,Tievsky AV, Ostergaard L, et al. Contrast agents in functional MR imaging[J]. JMRI, 1997,7(1) :47-51.
5Moonis M, Fisher M. Imaging of acuter stoke [J]. Cerebrovase Dis,2001,11(3) : 143-150.
6Maeda M, Yuh WT, Ueda T, et al. Severe occlusive carotid artery disease : hemodynamic assessment by MR perfusion imaging in symptomatic patients[J]. AJNR Am J Neuroradiol, 1999,20( 1 ) :43-51.
7Aronen HJ,Gazit IE, Louis DN, et al. Cerebral blood voiume map of gliomas；comparison with tumor grade and histologic findings[J]. Radiology, 1994,191(1) :41-51.
8Lee SJ, Kim JH, Kim YM, et al. Perfusion MR imaging in gliomas:comparison with histologic tumor grade [J]. Korean J Radiol, 2001,2(1):1-7.
9Roberts HC, Roberts TP, Brasch RC, et al. Quantiative measurement of microvascular permeability in human Brain tumors achieved using dynamic cntrast-ehanced MR Imaging: correlation with histologic grade[J]. AJNR Am J Neuroradiol, 2000,21 (5) : 891-899.
10Knopp EA, Cha S, Johnson G,et al .Glial neoplasmes:dynamic contrastenhanced T2 ^* -weighted MR imaging [J]. Radiology, 1999, 211 ( 3 ) :791-798.
